Zobrazeno 1 - 10
of 43
pro vyhledávání: '"L. Khimion"'
Autor:
L. Khimion, I. Klymas
Publikováno v:
Health of Society. 2:41-47
В статті висвітлені основні рекомендації та поради щодо виявлення, оцінки та ведення жертви насильства в сім’ї в практиці сімейного лі
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::367f3a134adb5e1b277e44af993f1abf
https://doi.org/10.22141/2306-2436.2.3-4.2013.121841
https://doi.org/10.22141/2306-2436.2.3-4.2013.121841
Publikováno v:
Health of Society. 7:53-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41de3662143aee07757383b8293c722
https://doi.org/10.22141/2306-2436.7.1.2018.137729
https://doi.org/10.22141/2306-2436.7.1.2018.137729
Autor:
L. Khimion, I. Klymas
Publikováno v:
Health of Society. 5:66-68
The article presents the polymorbidity spectrum in rheumatoid arthritis and lupus erythematosus patients based on own research and discusses the role of family physician in these patients care.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a104a38d8e47515ef6d9412311ca630f
https://doi.org/10.22141/2306-2436.5.1-2.2016.121272
https://doi.org/10.22141/2306-2436.5.1-2.2016.121272
Autor:
L. Khimion, L. Timoshchuk
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 3(55) (2017)
The article discusses in detail the problem of the medico-social significance of early kidney damage in essential hypertension (EH) (according to the literature review and own research). Aim. To determine the prevalence of subclinical renal damage
Externí odkaz:
https://doaj.org/article/838d4637b5f049af83c5fd1be1141f76
Autor:
Svitlana Danylyuk, Tetiana Sytyuk, L. Khimion, Nataliia Kicha, Oleksandr Burianov, Oksana Yashchenko
Publikováno v:
Family Medicine. :8-13
The evidence base for use of different rehabilitation programs is discussed in the article. The most effective approaches to the rehabilitation organization and patients education are presented together with the different types of physical rehabilita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f4f973a30e0c79c014d8548a3fd0bbe
https://doi.org/10.30841/2307-5112.5-6.2020.224822
https://doi.org/10.30841/2307-5112.5-6.2020.224822
Autor:
Alina V Boiko, L. Khimion
Publikováno v:
Wiadomości Lekarskie. 73:914-919
Objective The aim: To determine the features of atherosclerotic process, cardiovascular risk in patients with PsA. Patients and methods Materials and methods: The study included 42 patients with PsA who did not have atherosclerotic CVD, diabetes, chr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::486dc0a5bd3e52f97ea305bc1185106c
https://doi.org/10.36740/wlek202005114
https://doi.org/10.36740/wlek202005114
Publikováno v:
Health of Society. 5:51-52
The data about changes in lipid profile in rheumatoid arthritis patients with autoimmune thyroiditis is given in the article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b2ad30658bfc42dd875000ef5c41158
https://doi.org/10.22141/2306-2436.5.1-2.2016.121279
https://doi.org/10.22141/2306-2436.5.1-2.2016.121279
Autor:
L. Khimion, H. Havryliuk
Publikováno v:
Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini. 2019:91-94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cac42b4d328462913b52548cc42c9071
https://doi.org/10.15407/internalmed2019.01.091
https://doi.org/10.15407/internalmed2019.01.091
Autor:
L. Khimion, H. Havryliuk
Publikováno v:
Journal of Clinical Orthopaedics and Trauma. 10:42-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8b991267f5b227172371f1f3d25771
https://doi.org/10.1016/j.jcot.2018.08.007
https://doi.org/10.1016/j.jcot.2018.08.007
Publikováno v:
Annals of the Rheumatic Diseases. 81:1652.3-1652
Backgroundthe number of patients with progressive chronic kidney disease (CKD) and the costs of their treatment is constantly increasing. Possibly, control of serum uric acid (sUA) levels with urate lowering therapy (ULT) drugs can slow the progressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0440d70aea7d1ca5ae531214f43e0bdc
https://doi.org/10.1136/annrheumdis-2022-eular.3997
https://doi.org/10.1136/annrheumdis-2022-eular.3997